“Floating Liquefied Natural Gas (Lng) Market To Register Capital Expenditure Of $7.17 Bn In 2016” Says Visiongain Report

11 September 2016
Energy

Visiongain’s new 315 page report the Floating Liquefied Natural Gas (FLNG) Market : CAPEX and Capacity Forecasts for LNG FPSOs and FSRUs indicates that capital expenditure (capex) on FLNG projects will total $7.17bn in 2016, with the liquefaction (LNG FPSO) part of the market worth $5.06bn, and the regasification (FSRU) part of the market seeing capex of $2.11bn.

The lead analyst of the report commented that, “The floating liquefied natural gas (FLNG) market is developing quickly, with the first LNG FPSOs scheduled for delivery in 2016 and the number of countries ordering FSRUs expanding. Though the impact of lower oil prices and an oversupplied LNG market are creating challenges for project economics, the FLNG market will continue to register strong growth over the coming decade.”

The report includes forecasts for the LNG FPSO and FSRU parts of the market, broken down into capex and capacity forecasts for 8 regional markets and 10 leading national markets. The report also includes capex forecasts by LNG FPSO component and capacity forecasts by LNG FPSO liquefaction technology. In addition, details and analysis are provided for all existing, under construction and planned LNG FPSO and FSRU vessels, while a companies’ chapter offers profiles and market shares for the leading companies in the FLNG market. An exclusive interview from Javid H. Talib from Black & Veatch provides expert opinion alongside visiongain’s forecasts and analysis.

The Floating Liquefied Natural Gas (FLNG) Market: 2016-2026: CAPEX and Capacity Forecasts for LNG FPSOs and FSRUs report will be of value to anyone who wants to better understand the industry and its dynamics. It will be useful for businesses already involved in segment of the LNG market, or for those wishing to enter this growing market in the future.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

Recent News

Visiongain Publishes Non-Destructive Testing (NDT) Market Report 2021-2031

India, China, Malaysia, and Brazil are all building new bridges, dams, railroads, power plants, and refineries as part of their infrastructural growth. As a result, demand for NDT and inspection services and equipment is expected to rise, propelling the expansion of businesses that provide these services and equipment.

14 October 2021

Read

Visiongain Publishes Liquefied Natural Gas (LNG) Storage Tank Market Report 2021-2031

In many key markets, the fundamental principles for LNG growth – such as falling domestic supply and increased need for energy – remain intact. In the meanwhile, cheap prices allow for extra penetration of LNG.

15 September 2021

Read

Visiongain Publishes Flexible Battery Storage Market Report 2021-2031

The proliferation of the internet and smartphones around the world, as well as increased focus on medical device R&D and adoption of advanced healthcare technologies, as well as rising expenditure on healthcare infrastructure development, particularly in developing economies, are all contributing to the growth of the wearable devices market.

14 September 2021

Read

Visiongain Publishes State-of-Charge (SoC) Market Report 2021-2031

Although the main growth sector in the electric vehicles is lithium batteries in a number of vital medical device, including the ventilators critical to this epidemic (EVs).

07 September 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever